Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Artificial Intelligence Monitoring Blind Spots of EGD on the Inspection Time and Dection Rate of Neoplastic Lesions

NCT05832411 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.

NCT NCT05832411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05832411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Artificial Intelligence Monitoring Blind Spots of EGD on the Inspection Time and Dection Rate of Neoplastic Lesions
Lead sponsor
Renmin Hospital of Wuhan University
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2023
Completion date
August 31, 2024
Enrollment
1,672 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

upper gastrointestinal symptoms